iDNA PGx CNS is a pharmacogenetics test that employs a non-invasive procedure conducted on an oral swab sample. This genetic analysis focuses on identifying specific gene polymorphisms (SNP) that interact with medications, enabling the assessment of drug metabolism, adverse effects, treatment response, and efficacy. The test provides valuable guidance to physicians, helping them tailor treatment options and dosages to each individual patient.